Q&A: What do the recent updates to the Declaration of Helsinki mean for clinical trial technology?
A conversation with Amanda Howley, Director of Services Solutions at Suvoda
Why eCOA belongs with IRT: connected data for mission-critical, time-sensitive moments in a clinical trial
By: Andrés Escallón, Vice President, eCOA Solutions Strategy
Supporting site sustainability with data
Originally published on the Greenphire website prior to the merger with Suvoda in 2025.
At...
The Suvoda Platform: innovation and architecture that delivers simplicity and customizability
This post is the second in a two-part blog series where E.K. Koh, Chief Product Officer at Suvoda...
What is the Suvoda Platform?
This post is the first in a two-part blog serieswhere E.K. Koh, Chief Product Officer at Suvoda and...
How do site payments impact clinical trial sustainability?
Originally published on the Greenphire website prior to the merger with Suvoda in 2025.
In the...
Navigating the next wave of innovation in eCOA: Addressing operational challenges in clinical trials
Author: Andrés Escallón, Vice President of eCOA Solutions Strategy
Snapshot:
- Streamlined o...
Helping biotechs overcome 4 key challenges
Originally published on the Greenphire website prior to the merger with Suvoda in 2025.
...
How eCOA enhances data management in clinical trials
Author: Andrés Escallón, Vice President of eCOA Solutions Strategy
Snapshot:
- Higher data quality...
Solving the payment puzzle: How smarter financial strategies improve trial performance
Originally published on the Greenphire website prior to the merger with Suvoda in 2025.
Snapshot: